Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 273

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 273
---
 kit, or 200 kits of Tisseel the 10 ml Tisseel kits per year at a fixed purchase price of $0.136 
 per unit. The payments under the Supply Agreement are due 30 days from the date of invoice and the Company is subject to a service  
 charge of 1% per month on all amounts past due.                                                                                     |

The Supply Agreement had an initial term
of 3 years which ended on April 1, 2011; however, the Supply Agreement has an ever-green clause and is automatically renewable for consecutive
1 year terms unless either party gives notice of termination at least 3 months prior to the then current term. The Supply Agreement may
be terminated without cause by Baxter upon 90 days’ prior written notice to the other parties. In addition, either party may terminate
the Supply Agreement in the event of an uncured material breach or insolvency.

<div align='center'>F-22</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 9:- | COMMITMENTS AND CONTINGENCIES (Cont.) |

| 4. | In January 2024, the Company renewed its facility lease agreement until December 2024. The monthly                 
 rental obligations under non-cancellable leases are approximately $5.5 (including $3 for administrative expenses). |

As part of the agreement, the Company
has provided the landlord with a bank guarantee of approximately of $7 (NIS 27 thousand) which is valid until February 2025.

Future minimum lease payments under non-cancelable
operating leases as of December 31, 2024 are as follows:

| 2025 |     | USD | 66 |
|:-----|:----|:----|---:|
|      |     | $   | 66 |

The Company has elected to utilize the
practical expedient in ASC 842 for short-term leases (less than 12 months) whereby a lease liability and right of use asset will not
be recorded for short-term leases.

| 5. | In 2019,                                                                                                                                  
 a disagreement has arisen between the Company and CSL Behring GmbH, or CSL, whether certain unshipped minimum purchase commitments        
 for fibrinogen from 2018 to 2020 are to be paid by the Company pursuant to a Framework Supply Agreement dated March 8, 2016, or Framework